Zika vaccine shows promise in early human trial

Published: 4/10/2017
Zika vaccine shows promise in early human trial
Source: FEEDS.REUTERS.COM

CHICAGO (Reuters) - A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.

Read more
Related news
Comment
Latest in blog
FACEBOOK